Vestal Point Capital »

Savara shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Savara (SVRA) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $26M 6.5M 4.03

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
TCG Crossover Management
Adage Capital Partners GP
Frazier Life Sciences Management
BlackRock
Vanguard Group
Vestal Point Capital
Jennison Associates
Sofinnova Ventures
Nantahala Capital Management
Farallon Capital Management
State Street Corporation
Wellington Management Company
Geode Capital Management

View all funds holding Savara